Table 3. Analysis of the efficacy of the two groups of drugs on the rate of conversion to 14 HPVs [n (%)].

Subtype	Paiteling Group		Interferon Group		X 2	P-value a
	Total cases	Conversion rate	Total cases	Conversion rate
HPV
16	53	40(75.5)	25	6(24.0)	18.601	<0.001
18	18	11(61.1)	13	3(23.1)	4.409	0.036
31	5	4(80.0)	2	2(100.0)	0.467	1
33	8	6(75.0)	3	0(0.00)	4.950	0.061
35	-	-	5	3(60.0)	-	-
39	11	9(81.8)	11	7(63.6)	0.917	0.635
45	1	1(100)	1	1(100)	-	-
51	5	5(100)	15	7(46.7)	4.444	0.055
52	31	25(80.6)	21	8(38.1)	9.775	0.002
56	5	5(100)	5	1(20.0)	6.667	0.048
58	17	9(52.9)	25	7(28.0)	2.669	0.102
59	6	5(83.3)	4	3(75.0)	0.104	1
66	6	5(83.3)	5	2(40.0)	2.213	0.242
68	7	7(100)	4	1(25.0)	7.219	0.024
Total	173	132(76.3)	139	51(36.7)	9.864	<0.001

HPV: human papillomavirus.

^aP-value was calculated either by chi-square test or Fisher’s exact test.